2 research outputs found
Targeting the SH2-Kinase Interface in Bcr-Abl Inhibits Leukemogenesis
Intramolecular interaction between two domains of Bcr-Abl is essential for its oncogenic activity. Disrupting the interaction prevents leukemia, even in cases where Bcr-Abl has become resistant to existing kinase inhibitors